Celcuity, Inc. (NASDAQ:CELC) Stock Has Consensus Price Target of $154.25 According to Analysts

Celcuity, Inc. (NASDAQ:CELC) has earned an average rating of “Moderate Buy” from the twelve analysts that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating and eleven have given a buy rating to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $154.25.

Several research analysts recently weighed in on CELC shares. Citizens Jmp restated a “market outperform” rating and set a $177.00 price target on shares of Celcuity in a report on Monday, August 17th. Stifel Nicolaus decreased their price objective on shares of Celcuity from $175.00 to $150.00 and set a “buy” rating for the company in a research note on Friday, August 14th. JPMorgan Chase & Co. started coverage on shares of Celcuity in a research report on Thursday, September 17th. They set an “overweight” rating and a $157.00 target price on the stock. Weiss Ratings restated a “sell (d-)” rating on shares of Celcuity in a research note on Tuesday, September 1st. Finally, Citigroup restated a “market outperform” rating on shares of Celcuity in a research note on Monday, August 17th.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Parallel Advisors LLC purchased a new stake in shares of Celcuity during the 1st quarter valued at $38,000. EverSource Wealth Advisors LLC boosted its holdings in shares of Celcuity by 1,329.2% in the 4th quarter. EverSource Wealth Advisors LLC now owns 343 shares of the company’s stock worth $34,000 after buying an additional 319 shares during the last quarter. PNC Financial Services Group Inc. boosted its holdings in shares of Celcuity by 20.1% in the 1st quarter. PNC Financial Services Group Inc. now owns 514 shares of the company’s stock worth $59,000 after buying an additional 86 shares during the last quarter. KBC Group NV purchased a new position in shares of Celcuity in the 1st quarter worth about $64,000. Finally, IFP Advisors Inc bought a new position in Celcuity during the second quarter valued at about $73,000. Hedge funds and other institutional investors own 63.33% of the company’s stock.

Celcuity Stock Performance

NASDAQ CELC opened at $72.10 on Friday. The company has a current ratio of 8.93, a quick ratio of 8.93 and a debt-to-equity ratio of 6.04. The business has a fifty day simple moving average of $87.52 and a 200 day simple moving average of $102.85. Celcuity has a 12 month low of $45.03 and a 12 month high of $151.02. The firm has a market capitalization of $3.53 billion, a P/E ratio of -16.77 and a beta of 0.10.

Celcuity (NASDAQ:CELC) last posted its quarterly earnings data on Thursday, August 13th. The company reported ($1.44) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.16) by ($0.28). On average, analysts predict that Celcuity will post -4.82 EPS for the current fiscal year.

About Celcuity

Celcuity, Inc is a clinical-stage biotechnology company that develops functional diagnostic tests designed to help identify patients who may benefit from targeted cancer therapies. The company’s technology is intended to measure the activity of cellular signaling networks in living tumor cells, rather than relying solely on the presence or absence of individual biomarkers.

Celcuity’s proprietary CELsignia platform analyzes patient tumor samples to identify abnormal signaling activity associated with cancer growth and treatment response.